Abpro Holdings, Inc. SEC filings ABPO

Abpro Holdings, Inc. has 253 filings in SEC EDGAR's recent list, going back to Dec 2, 2021. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 20, 2026 Mar 31, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 26, 2024 Sep 30, 2024
10-Q Quarterly report Aug 23, 2024 Jun 30, 2024
10-Q Quarterly report Jul 9, 2024 Mar 31, 2024
10-Q Quarterly report Dec 15, 2023 Sep 30, 2023
10-Q Quarterly report Aug 22, 2023 Jun 30, 2023
10-Q Quarterly report May 22, 2023 Mar 31, 2023
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
10-Q Quarterly report May 20, 2022 Mar 31, 2022

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ABPO (OTC), ABPWW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1893219
Former names
Atlantic Coastal Acquisition Corp. II (until Nov 12, 2024)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.